MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 7.30
-0.38 (-4.95%)
At close: Jan 30, 2026
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €117.57 million as of January 30, 2026. Its market cap has increased by 2.07% in one year.
Market Cap
117.57M
Enterprise Value
116.94M
Revenue
3.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
€7.30
Market Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has decreased from 132.73M to 117.57M, a decrease of -11.42%. That is a compound annual growth rate of -2.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 117.57M | 51.77% |
| Dec 31, 2025 | 77.47M | -29.96% |
| Dec 31, 2024 | 110.61M | 36.57% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
| Nov 8, 2021 | 132.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genfit | 283.83M |
| Transgene | 251.37M |
| Cellectis | 247.35M |
| Innate Pharma | 141.49M |
| ABIONYX Pharma | 137.94M |
| Adocia | 119.32M |
| Sensorion | 112.63M |
| OSE Immunotherapeutics | 108.02M |